BPC
CBIO

Banque Pictet & Cie’s Crescent Biopharma CBIO Stock Holding History

Banque Pictet & Cie’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-126
Closed -$88K – 492
2014
Q3 		$88K Sell
126
-4
-3% -$3.24K ﹤0.01% 456
2014
Q2 		$109K Buy
130
+20
+18% +$19.9K ﹤0.01% 452
2014
Q1 		$180K Buy
+110
New +$133K ﹤0.01% 398

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
MSA
Mason Street Advisors Milwaukee, Wisconsin $1.11B AUM 12.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Banque Pictet & Cie's CBIO Position: Q4 2014 in Review

Banque Pictet & Cie sold out of Crescent Biopharma (CBIO) in Q4 2014, closing a stake of 126 shares — an estimated $88K sold.

Banque Pictet & Cie first reported a position in CBIO in Q1 2014 and held it in 3 quarters. The position peaked at $180K in Q1 2014. 28 funds tracked by Wall St. Rank hold CBIO as of Q4 2014.

  • Banque Pictet & Cie reported no remaining Crescent Biopharma position as of Q4 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 126 Crescent Biopharma shares in Q4 2014, an estimated $88K.
  • Banque Pictet & Cie first reported a position in Crescent Biopharma in Q1 2014 and held it in 3 quarters.
  • Banque Pictet & Cie's Crescent Biopharma position peaked at $180K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Crescent Biopharma as of Q4 2014.

Based on Banque Pictet & Cie's 13F filing for Q4 2014, filed 12 Feb 2015.